nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCB1—lung cancer	0.112	1	CbGaD
Carbamazepine—RALBP1—Doxorubicin—lung cancer	0.09	0.15	CbGbCtD
Carbamazepine—ABCC2—Paclitaxel—lung cancer	0.0175	0.0293	CbGbCtD
Carbamazepine—ABCC2—Irinotecan—lung cancer	0.0173	0.0289	CbGbCtD
Carbamazepine—CYP3A5—Gefitinib—lung cancer	0.0162	0.0271	CbGbCtD
Carbamazepine—CYP3A5—Teniposide—lung cancer	0.0157	0.0263	CbGbCtD
Carbamazepine—ABCC2—Vinblastine—lung cancer	0.0154	0.0257	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—lung cancer	0.0141	0.0235	CbGbCtD
Carbamazepine—ABCC2—Etoposide—lung cancer	0.0138	0.0231	CbGbCtD
Carbamazepine—CYP2C19—Gefitinib—lung cancer	0.0131	0.0218	CbGbCtD
Carbamazepine—CYP2C19—Teniposide—lung cancer	0.0127	0.0212	CbGbCtD
Carbamazepine—ABCC2—Docetaxel—lung cancer	0.0127	0.0212	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0117	0.0195	CbGbCtD
Carbamazepine—CYP3A7—Paclitaxel—lung cancer	0.0117	0.0195	CbGbCtD
Carbamazepine—CYP3A7—Irinotecan—lung cancer	0.0115	0.0193	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0115	0.0193	CbGbCtD
Carbamazepine—ABCB1—Topotecan—lung cancer	0.0115	0.0193	CbGbCtD
Carbamazepine—CYP2B6—Irinotecan—lung cancer	0.011	0.0184	CbGbCtD
Carbamazepine—CYP2C9—Gefitinib—lung cancer	0.0109	0.0182	CbGbCtD
Carbamazepine—ABCB1—Gefitinib—lung cancer	0.0106	0.0176	CbGbCtD
Carbamazepine—CYP2C9—Teniposide—lung cancer	0.0105	0.0176	CbGbCtD
Carbamazepine—CYP3A5—Crizotinib—lung cancer	0.00994	0.0166	CbGbCtD
Carbamazepine—CYP3A5—Erlotinib—lung cancer	0.00959	0.016	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—lung cancer	0.00944	0.0158	CbGbCtD
Carbamazepine—CYP2C8—Erlotinib—lung cancer	0.00922	0.0154	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—lung cancer	0.00915	0.0153	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—lung cancer	0.00896	0.015	CbGbCtD
Carbamazepine—CYP3A5—Paclitaxel—lung cancer	0.00877	0.0147	CbGbCtD
Carbamazepine—CYP3A5—Irinotecan—lung cancer	0.00866	0.0145	CbGbCtD
Carbamazepine—CYP3A7—Docetaxel—lung cancer	0.00846	0.0141	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00846	0.0141	CbGbCtD
Carbamazepine—CYP2C8—Paclitaxel—lung cancer	0.00844	0.0141	CbGbCtD
Carbamazepine—ABCB1—Vinorelbine—lung cancer	0.00813	0.0136	CbGbCtD
Carbamazepine—CYP1A2—Erlotinib—lung cancer	0.00713	0.0119	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—lung cancer	0.00693	0.0116	CbGbCtD
Carbamazepine—CYP3A4—Topotecan—lung cancer	0.00691	0.0115	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—lung cancer	0.00667	0.0111	CbGbCtD
Carbamazepine—ABCB1—Crizotinib—lung cancer	0.00647	0.0108	CbGbCtD
Carbamazepine—CYP3A5—Docetaxel—lung cancer	0.00634	0.0106	CbGbCtD
Carbamazepine—CYP3A4—Gefitinib—lung cancer	0.00632	0.0106	CbGbCtD
Carbamazepine—ABCB1—Gemcitabine—lung cancer	0.00632	0.0106	CbGbCtD
Carbamazepine—ABCB1—Erlotinib—lung cancer	0.00624	0.0104	CbGbCtD
Carbamazepine—CYP3A4—Teniposide—lung cancer	0.00613	0.0102	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—lung cancer	0.006	0.01	CbGbCtD
Carbamazepine—CYP2C9—Paclitaxel—lung cancer	0.00588	0.00983	CbGbCtD
Carbamazepine—ABCB1—Paclitaxel—lung cancer	0.00571	0.00954	CbGbCtD
Carbamazepine—ABCB1—Irinotecan—lung cancer	0.00563	0.00941	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—lung cancer	0.00516	0.00862	CbGbCtD
Carbamazepine—ABCB1—Vinblastine—lung cancer	0.00501	0.00837	CbGbCtD
Carbamazepine—CYP3A4—Vinorelbine—lung cancer	0.00487	0.00813	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—lung cancer	0.00473	0.0079	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—lung cancer	0.00459	0.00767	CbGbCtD
Carbamazepine—ABCB1—Etoposide—lung cancer	0.00451	0.00754	CbGbCtD
Carbamazepine—ABCB1—Docetaxel—lung cancer	0.00413	0.0069	CbGbCtD
Carbamazepine—CYP3A4—Crizotinib—lung cancer	0.00387	0.00647	CbGbCtD
Carbamazepine—CYP3A4—Erlotinib—lung cancer	0.00374	0.00624	CbGbCtD
Carbamazepine—CYP3A4—Paclitaxel—lung cancer	0.00342	0.00572	CbGbCtD
Carbamazepine—CYP3A4—Irinotecan—lung cancer	0.00338	0.00564	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—lung cancer	0.00308	0.00514	CbGbCtD
Carbamazepine—CYP3A4—Vinblastine—lung cancer	0.003	0.00501	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—lung cancer	0.00298	0.00498	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—lung cancer	0.0027	0.00452	CbGbCtD
Carbamazepine—CYP3A4—Docetaxel—lung cancer	0.00247	0.00413	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—lung cancer	0.00184	0.00308	CbGbCtD
Carbamazepine—Nepafenac—PTGS2—lung cancer	0.000225	0.108	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—lung cancer	0.00022	0.105	CrCbGaD
Carbamazepine—Magnesium salicylate—ALB—lung cancer	0.000196	0.0939	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—lung cancer	0.000187	0.0896	CrCbGaD
Carbamazepine—Salsalate—PTGS2—lung cancer	0.000187	0.0896	CrCbGaD
Carbamazepine—Protriptyline—ABCB1—lung cancer	0.000162	0.0774	CrCbGaD
Carbamazepine—Desipramine—CYP2A6—lung cancer	0.000137	0.0656	CrCbGaD
Carbamazepine—Epinastine—ABCB1—lung cancer	0.00012	0.0573	CrCbGaD
Carbamazepine—Oxcarbazepine—ALB—lung cancer	0.000116	0.0554	CrCbGaD
Carbamazepine—Desipramine—CYP2E1—lung cancer	9.74e-05	0.0466	CrCbGaD
Carbamazepine—Imipramine—CYP2E1—lung cancer	8.26e-05	0.0395	CrCbGaD
Carbamazepine—Phenytoin—ALB—lung cancer	7.67e-05	0.0367	CrCbGaD
Carbamazepine—Phenytoin—ABCB1—lung cancer	7.32e-05	0.035	CrCbGaD
Carbamazepine—Trimipramine—ABCB1—lung cancer	5.84e-05	0.0279	CrCbGaD
Carbamazepine—Promethazine—ABCB1—lung cancer	5.62e-05	0.0269	CrCbGaD
Carbamazepine—Hepatitis—Methotrexate—lung cancer	5.26e-05	0.000291	CcSEcCtD
Carbamazepine—Pollakiuria—Doxorubicin—lung cancer	5.25e-05	0.000291	CcSEcCtD
Carbamazepine—Asthenia—Gemcitabine—lung cancer	5.24e-05	0.00029	CcSEcCtD
Carbamazepine—Pain—Paclitaxel—lung cancer	5.23e-05	0.000289	CcSEcCtD
Carbamazepine—Constipation—Paclitaxel—lung cancer	5.23e-05	0.000289	CcSEcCtD
Carbamazepine—Confusional state—Docetaxel—lung cancer	5.22e-05	0.000289	CcSEcCtD
Carbamazepine—Pharyngitis—Methotrexate—lung cancer	5.22e-05	0.000289	CcSEcCtD
Carbamazepine—Urinary tract disorder—Methotrexate—lung cancer	5.19e-05	0.000287	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—lung cancer	5.19e-05	0.000287	CcSEcCtD
Carbamazepine—Oedema—Docetaxel—lung cancer	5.18e-05	0.000287	CcSEcCtD
Carbamazepine—Anaphylactic shock—Docetaxel—lung cancer	5.18e-05	0.000287	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—lung cancer	5.17e-05	0.000286	CcSEcCtD
Carbamazepine—Pruritus—Gemcitabine—lung cancer	5.16e-05	0.000286	CcSEcCtD
Carbamazepine—Urethral disorder—Methotrexate—lung cancer	5.15e-05	0.000285	CcSEcCtD
Carbamazepine—Infection—Docetaxel—lung cancer	5.15e-05	0.000285	CcSEcCtD
Carbamazepine—Feeling abnormal—Etoposide—lung cancer	5.14e-05	0.000284	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—lung cancer	5.13e-05	0.000284	CcSEcCtD
Carbamazepine—Diarrhoea—Irinotecan—lung cancer	5.13e-05	0.000284	CcSEcCtD
Carbamazepine—Desipramine—ABCB1—lung cancer	5.1e-05	0.0244	CrCbGaD
Carbamazepine—Pneumonia—Doxorubicin—lung cancer	5.1e-05	0.000282	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Etoposide—lung cancer	5.1e-05	0.000282	CcSEcCtD
Carbamazepine—Shock—Docetaxel—lung cancer	5.1e-05	0.000282	CcSEcCtD
Carbamazepine—Nervous system disorder—Docetaxel—lung cancer	5.08e-05	0.000281	CcSEcCtD
Carbamazepine—Thrombocytopenia—Docetaxel—lung cancer	5.07e-05	0.000281	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—lung cancer	5.07e-05	0.00028	CcSEcCtD
Carbamazepine—Infestation NOS—Doxorubicin—lung cancer	5.07e-05	0.00028	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—lung cancer	5.07e-05	0.00028	CcSEcCtD
Carbamazepine—Tachycardia—Docetaxel—lung cancer	5.06e-05	0.00028	CcSEcCtD
Carbamazepine—Feeling abnormal—Paclitaxel—lung cancer	5.04e-05	0.000279	CcSEcCtD
Carbamazepine—Skin disorder—Docetaxel—lung cancer	5.03e-05	0.000278	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.03e-05	0.000278	CcSEcCtD
Carbamazepine—Hypersensitivity—Cisplatin—lung cancer	5.01e-05	0.000277	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Paclitaxel—lung cancer	5e-05	0.000276	CcSEcCtD
Carbamazepine—Diarrhoea—Gemcitabine—lung cancer	4.99e-05	0.000276	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—lung cancer	4.98e-05	0.000276	CcSEcCtD
Carbamazepine—Erythema multiforme—Methotrexate—lung cancer	4.97e-05	0.000275	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—lung cancer	4.97e-05	0.000275	CcSEcCtD
Carbamazepine—Dizziness—Irinotecan—lung cancer	4.96e-05	0.000274	CcSEcCtD
Carbamazepine—Urticaria—Etoposide—lung cancer	4.95e-05	0.000274	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—lung cancer	4.94e-05	0.000273	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—lung cancer	4.94e-05	0.000273	CcSEcCtD
Carbamazepine—Anorexia—Docetaxel—lung cancer	4.94e-05	0.000273	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—lung cancer	4.93e-05	0.000273	CcSEcCtD
Carbamazepine—Body temperature increased—Etoposide—lung cancer	4.93e-05	0.000273	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—lung cancer	4.93e-05	0.000273	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—lung cancer	4.93e-05	0.000273	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—lung cancer	4.91e-05	0.000272	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—lung cancer	4.9e-05	0.000271	CcSEcCtD
Carbamazepine—Asthenia—Cisplatin—lung cancer	4.88e-05	0.00027	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—lung cancer	4.88e-05	0.00027	CcSEcCtD
Carbamazepine—Urticaria—Paclitaxel—lung cancer	4.86e-05	0.000269	CcSEcCtD
Carbamazepine—Hypotension—Docetaxel—lung cancer	4.84e-05	0.000268	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—lung cancer	4.83e-05	0.000267	CcSEcCtD
Carbamazepine—Abdominal pain—Paclitaxel—lung cancer	4.83e-05	0.000267	CcSEcCtD
Carbamazepine—Body temperature increased—Paclitaxel—lung cancer	4.83e-05	0.000267	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—lung cancer	4.79e-05	0.000265	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—lung cancer	4.77e-05	0.000264	CcSEcCtD
Carbamazepine—Vomiting—Irinotecan—lung cancer	4.76e-05	0.000264	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—lung cancer	4.76e-05	0.000263	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—lung cancer	4.75e-05	0.000263	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—lung cancer	4.74e-05	0.000262	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—lung cancer	4.73e-05	0.000262	CcSEcCtD
Carbamazepine—Rash—Irinotecan—lung cancer	4.73e-05	0.000261	CcSEcCtD
Carbamazepine—Dermatitis—Irinotecan—lung cancer	4.72e-05	0.000261	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Docetaxel—lung cancer	4.72e-05	0.000261	CcSEcCtD
Carbamazepine—Chills—Methotrexate—lung cancer	4.72e-05	0.000261	CcSEcCtD
Carbamazepine—Headache—Irinotecan—lung cancer	4.69e-05	0.00026	CcSEcCtD
Carbamazepine—Insomnia—Docetaxel—lung cancer	4.69e-05	0.000259	CcSEcCtD
Carbamazepine—Diarrhoea—Cisplatin—lung cancer	4.66e-05	0.000258	CcSEcCtD
Carbamazepine—Paraesthesia—Docetaxel—lung cancer	4.65e-05	0.000257	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—lung cancer	4.64e-05	0.000257	CcSEcCtD
Carbamazepine—Vomiting—Gemcitabine—lung cancer	4.64e-05	0.000257	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—lung cancer	4.63e-05	0.000256	CcSEcCtD
Carbamazepine—Dyspnoea—Docetaxel—lung cancer	4.62e-05	0.000255	CcSEcCtD
Carbamazepine—Somnolence—Docetaxel—lung cancer	4.61e-05	0.000255	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—lung cancer	4.6e-05	0.000255	CcSEcCtD
Carbamazepine—Rash—Gemcitabine—lung cancer	4.6e-05	0.000255	CcSEcCtD
Carbamazepine—Dermatitis—Gemcitabine—lung cancer	4.6e-05	0.000254	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—lung cancer	4.59e-05	0.000254	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—lung cancer	4.58e-05	0.000253	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—lung cancer	4.58e-05	0.000253	CcSEcCtD
Carbamazepine—Headache—Gemcitabine—lung cancer	4.57e-05	0.000253	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—lung cancer	4.56e-05	0.000252	CcSEcCtD
Carbamazepine—Dyspepsia—Docetaxel—lung cancer	4.56e-05	0.000252	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—lung cancer	4.55e-05	0.000252	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—lung cancer	4.52e-05	0.00025	CcSEcCtD
Carbamazepine—Decreased appetite—Docetaxel—lung cancer	4.5e-05	0.000249	CcSEcCtD
Carbamazepine—Hypersensitivity—Paclitaxel—lung cancer	4.5e-05	0.000249	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—lung cancer	4.49e-05	0.000249	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—lung cancer	4.48e-05	0.000248	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—lung cancer	4.48e-05	0.000248	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Docetaxel—lung cancer	4.47e-05	0.000247	CcSEcCtD
Carbamazepine—Asthenia—Etoposide—lung cancer	4.47e-05	0.000247	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—lung cancer	4.47e-05	0.000247	CcSEcCtD
Carbamazepine—Fatigue—Docetaxel—lung cancer	4.47e-05	0.000247	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—lung cancer	4.46e-05	0.000247	CcSEcCtD
Carbamazepine—Nausea—Irinotecan—lung cancer	4.45e-05	0.000246	CcSEcCtD
Carbamazepine—Pain—Docetaxel—lung cancer	4.43e-05	0.000245	CcSEcCtD
Carbamazepine—Constipation—Docetaxel—lung cancer	4.43e-05	0.000245	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—lung cancer	4.43e-05	0.000245	CcSEcCtD
Carbamazepine—Pruritus—Etoposide—lung cancer	4.41e-05	0.000244	CcSEcCtD
Carbamazepine—Asthenia—Paclitaxel—lung cancer	4.39e-05	0.000243	CcSEcCtD
Carbamazepine—Nausea—Gemcitabine—lung cancer	4.34e-05	0.00024	CcSEcCtD
Carbamazepine—Imipramine—ABCB1—lung cancer	4.33e-05	0.0207	CrCbGaD
Carbamazepine—Vomiting—Cisplatin—lung cancer	4.33e-05	0.000239	CcSEcCtD
Carbamazepine—Pruritus—Paclitaxel—lung cancer	4.32e-05	0.000239	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—lung cancer	4.31e-05	0.000239	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—lung cancer	4.3e-05	0.000238	CcSEcCtD
Carbamazepine—Rash—Cisplatin—lung cancer	4.29e-05	0.000237	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—lung cancer	4.29e-05	0.000237	CcSEcCtD
Carbamazepine—Feeling abnormal—Docetaxel—lung cancer	4.27e-05	0.000236	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—lung cancer	4.27e-05	0.000236	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—lung cancer	4.25e-05	0.000235	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—lung cancer	4.24e-05	0.000235	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Docetaxel—lung cancer	4.24e-05	0.000234	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—lung cancer	4.23e-05	0.000234	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—lung cancer	4.22e-05	0.000234	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—lung cancer	4.22e-05	0.000234	CcSEcCtD
Carbamazepine—RALBP1—respiratory system—lung cancer	4.19e-05	0.0975	CbGeAlD
Carbamazepine—Diarrhoea—Paclitaxel—lung cancer	4.18e-05	0.000231	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—lung cancer	4.13e-05	0.000228	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—lung cancer	4.12e-05	0.000228	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—lung cancer	4.11e-05	0.000227	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—lung cancer	4.11e-05	0.000227	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—lung cancer	4.1e-05	0.000227	CcSEcCtD
Carbamazepine—Body temperature increased—Docetaxel—lung cancer	4.1e-05	0.000227	CcSEcCtD
Carbamazepine—Abdominal pain—Docetaxel—lung cancer	4.1e-05	0.000227	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—lung cancer	4.1e-05	0.000227	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—lung cancer	4.08e-05	0.000226	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—lung cancer	4.07e-05	0.000225	CcSEcCtD
Carbamazepine—Dizziness—Paclitaxel—lung cancer	4.04e-05	0.000224	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—lung cancer	4.04e-05	0.000224	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—lung cancer	4.02e-05	0.000222	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—lung cancer	3.99e-05	0.000221	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—lung cancer	3.96e-05	0.000219	CcSEcCtD
Carbamazepine—Vomiting—Etoposide—lung cancer	3.96e-05	0.000219	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—lung cancer	3.96e-05	0.000219	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—lung cancer	3.96e-05	0.000219	CcSEcCtD
Carbamazepine—Rash—Etoposide—lung cancer	3.93e-05	0.000217	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—lung cancer	3.93e-05	0.000217	CcSEcCtD
Carbamazepine—Headache—Etoposide—lung cancer	3.91e-05	0.000216	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—lung cancer	3.89e-05	0.000215	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—lung cancer	3.89e-05	0.000215	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—lung cancer	3.89e-05	0.000215	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—lung cancer	3.89e-05	0.000215	CcSEcCtD
Carbamazepine—Vomiting—Paclitaxel—lung cancer	3.89e-05	0.000215	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—lung cancer	3.88e-05	0.000215	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.87e-05	0.000214	CcSEcCtD
Carbamazepine—Rash—Paclitaxel—lung cancer	3.85e-05	0.000213	CcSEcCtD
Carbamazepine—Dermatitis—Paclitaxel—lung cancer	3.85e-05	0.000213	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—lung cancer	3.85e-05	0.000213	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—lung cancer	3.83e-05	0.000212	CcSEcCtD
Carbamazepine—Headache—Paclitaxel—lung cancer	3.83e-05	0.000212	CcSEcCtD
Carbamazepine—Hypersensitivity—Docetaxel—lung cancer	3.82e-05	0.000211	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—lung cancer	3.81e-05	0.000211	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—lung cancer	3.76e-05	0.000208	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—lung cancer	3.73e-05	0.000207	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—lung cancer	3.73e-05	0.000207	CcSEcCtD
Carbamazepine—Asthenia—Docetaxel—lung cancer	3.72e-05	0.000206	CcSEcCtD
Carbamazepine—Infection—Methotrexate—lung cancer	3.71e-05	0.000205	CcSEcCtD
Carbamazepine—Nausea—Etoposide—lung cancer	3.7e-05	0.000205	CcSEcCtD
Carbamazepine—Pruritus—Docetaxel—lung cancer	3.67e-05	0.000203	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—lung cancer	3.66e-05	0.000203	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—lung cancer	3.66e-05	0.000203	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—lung cancer	3.66e-05	0.000202	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—lung cancer	3.64e-05	0.000201	CcSEcCtD
Carbamazepine—Nausea—Paclitaxel—lung cancer	3.63e-05	0.000201	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—lung cancer	3.63e-05	0.000201	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—lung cancer	3.61e-05	0.0002	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—lung cancer	3.56e-05	0.000197	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—lung cancer	3.56e-05	0.000197	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—lung cancer	3.55e-05	0.000197	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—lung cancer	3.55e-05	0.000196	CcSEcCtD
Carbamazepine—Diarrhoea—Docetaxel—lung cancer	3.54e-05	0.000196	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—lung cancer	3.49e-05	0.000193	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—lung cancer	3.48e-05	0.000193	CcSEcCtD
Carbamazepine—RALBP1—bronchus—lung cancer	3.44e-05	0.0803	CbGeAlD
Carbamazepine—Convulsion—Doxorubicin—lung cancer	3.43e-05	0.00019	CcSEcCtD
Carbamazepine—Dizziness—Docetaxel—lung cancer	3.43e-05	0.00019	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—lung cancer	3.42e-05	0.000189	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—lung cancer	3.4e-05	0.000188	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—lung cancer	3.38e-05	0.000187	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—lung cancer	3.37e-05	0.000187	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—lung cancer	3.37e-05	0.000187	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—lung cancer	3.37e-05	0.000187	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—lung cancer	3.36e-05	0.000186	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—lung cancer	3.35e-05	0.000185	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.35e-05	0.000185	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—lung cancer	3.33e-05	0.000184	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—lung cancer	3.32e-05	0.000184	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—lung cancer	3.3e-05	0.000182	CcSEcCtD
Carbamazepine—Vomiting—Docetaxel—lung cancer	3.29e-05	0.000182	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—lung cancer	3.29e-05	0.000182	CcSEcCtD
Carbamazepine—Rash—Docetaxel—lung cancer	3.27e-05	0.000181	CcSEcCtD
Carbamazepine—Dermatitis—Docetaxel—lung cancer	3.26e-05	0.000181	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—lung cancer	3.26e-05	0.00018	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—lung cancer	3.25e-05	0.00018	CcSEcCtD
Carbamazepine—Headache—Docetaxel—lung cancer	3.25e-05	0.00018	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—lung cancer	3.23e-05	0.000179	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—lung cancer	3.23e-05	0.000179	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—lung cancer	3.22e-05	0.000178	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—lung cancer	3.22e-05	0.000178	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—lung cancer	3.21e-05	0.000178	CcSEcCtD
Carbamazepine—Pain—Methotrexate—lung cancer	3.19e-05	0.000177	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—lung cancer	3.18e-05	0.000176	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—lung cancer	3.17e-05	0.000175	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—lung cancer	3.17e-05	0.000175	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—lung cancer	3.16e-05	0.000175	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—lung cancer	3.14e-05	0.000174	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—lung cancer	3.13e-05	0.000173	CcSEcCtD
Carbamazepine—RALBP1—trachea—lung cancer	3.09e-05	0.0721	CbGeAlD
Carbamazepine—Anorexia—Doxorubicin—lung cancer	3.08e-05	0.00017	CcSEcCtD
Carbamazepine—Nausea—Docetaxel—lung cancer	3.08e-05	0.00017	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—lung cancer	3.08e-05	0.00017	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—lung cancer	3.05e-05	0.000169	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—lung cancer	3.02e-05	0.000167	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—lung cancer	2.97e-05	0.000164	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—lung cancer	2.95e-05	0.000163	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—lung cancer	2.95e-05	0.000163	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.95e-05	0.000163	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—lung cancer	2.92e-05	0.000162	CcSEcCtD
Carbamazepine—RALBP1—cardiac atrium—lung cancer	2.91e-05	0.0677	CbGeAlD
Carbamazepine—Paraesthesia—Doxorubicin—lung cancer	2.9e-05	0.000161	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—lung cancer	2.88e-05	0.000159	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—lung cancer	2.87e-05	0.000159	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—lung cancer	2.85e-05	0.000157	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—lung cancer	2.81e-05	0.000155	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—lung cancer	2.79e-05	0.000154	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—lung cancer	2.79e-05	0.000154	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—lung cancer	2.76e-05	0.000153	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—lung cancer	2.76e-05	0.000153	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—lung cancer	2.75e-05	0.000152	CcSEcCtD
Carbamazepine—Asthenia—Methotrexate—lung cancer	2.68e-05	0.000148	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—lung cancer	2.66e-05	0.000147	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—lung cancer	2.64e-05	0.000146	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—lung cancer	2.64e-05	0.000146	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—lung cancer	2.57e-05	0.000142	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—lung cancer	2.56e-05	0.000141	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—lung cancer	2.56e-05	0.000141	CcSEcCtD
Carbamazepine—Diarrhoea—Methotrexate—lung cancer	2.55e-05	0.000141	CcSEcCtD
Carbamazepine—CYP2C8—mammary gland—lung cancer	2.53e-05	0.0589	CbGeAlD
Carbamazepine—Dizziness—Methotrexate—lung cancer	2.47e-05	0.000137	CcSEcCtD
Carbamazepine—RALBP1—bone marrow—lung cancer	2.45e-05	0.0572	CbGeAlD
Carbamazepine—Hypersensitivity—Doxorubicin—lung cancer	2.38e-05	0.000132	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—lung cancer	2.37e-05	0.000131	CcSEcCtD
Carbamazepine—Rash—Methotrexate—lung cancer	2.35e-05	0.00013	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—lung cancer	2.35e-05	0.00013	CcSEcCtD
Carbamazepine—Headache—Methotrexate—lung cancer	2.34e-05	0.000129	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—lung cancer	2.32e-05	0.000128	CcSEcCtD
Carbamazepine—SCN9A—lung—lung cancer	2.3e-05	0.0535	CbGeAlD
Carbamazepine—Pruritus—Doxorubicin—lung cancer	2.29e-05	0.000127	CcSEcCtD
Carbamazepine—CYP2C9—mammary gland—lung cancer	2.24e-05	0.0523	CbGeAlD
Carbamazepine—RALBP1—lung—lung cancer	2.22e-05	0.0518	CbGeAlD
Carbamazepine—Nausea—Methotrexate—lung cancer	2.22e-05	0.000123	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—lung cancer	2.21e-05	0.000122	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—lung cancer	2.14e-05	0.000118	CcSEcCtD
Carbamazepine—SCN5A—cardiac atrium—lung cancer	2.08e-05	0.0484	CbGeAlD
Carbamazepine—Vomiting—Doxorubicin—lung cancer	2.06e-05	0.000114	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—lung cancer	2.04e-05	0.000113	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—lung cancer	2.04e-05	0.000113	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—lung cancer	2.03e-05	0.000112	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—lung cancer	1.92e-05	0.000106	CcSEcCtD
Carbamazepine—CYP1A2—respiratory system—lung cancer	1.58e-05	0.0367	CbGeAlD
Carbamazepine—SCN9A—lymph node—lung cancer	1.57e-05	0.0366	CbGeAlD
Carbamazepine—RALBP1—lymph node—lung cancer	1.52e-05	0.0354	CbGeAlD
Carbamazepine—CYP3A5—respiratory system—lung cancer	1.52e-05	0.0354	CbGeAlD
Carbamazepine—CYP2B6—respiratory system—lung cancer	1.51e-05	0.0352	CbGeAlD
Carbamazepine—CYP2B6—bronchus—lung cancer	1.24e-05	0.029	CbGeAlD
Carbamazepine—CYP1A2—lung—lung cancer	8.37e-06	0.0195	CbGeAlD
Carbamazepine—ABCC2—lymph node—lung cancer	8.15e-06	0.019	CbGeAlD
Carbamazepine—ABCB1—respiratory system—lung cancer	8.07e-06	0.0188	CbGeAlD
Carbamazepine—CYP3A5—lung—lung cancer	8.07e-06	0.0188	CbGeAlD
Carbamazepine—CYP2B6—lung—lung cancer	8.02e-06	0.0187	CbGeAlD
Carbamazepine—ABCB1—epithelium—lung cancer	6.75e-06	0.0157	CbGeAlD
Carbamazepine—ABCB1—trachea—lung cancer	5.97e-06	0.0139	CbGeAlD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.3e-06	4.98e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—RRM1—lung cancer	5.29e-06	4.97e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA3—lung cancer	5.29e-06	4.97e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTT1—lung cancer	5.29e-06	4.97e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.29e-06	4.97e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNG11—lung cancer	5.29e-06	4.96e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.26e-06	4.94e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.24e-06	4.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP2A6—lung cancer	5.23e-06	4.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GCLC—lung cancer	5.23e-06	4.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.21e-06	4.89e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTP1—lung cancer	5.2e-06	4.89e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CAT—lung cancer	5.18e-06	4.86e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CAT—lung cancer	5.06e-06	4.75e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—lung cancer	5.04e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALDOA—lung cancer	5.03e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—B4GALT5—lung cancer	4.98e-06	4.67e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.96e-06	4.66e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO1—lung cancer	4.96e-06	4.66e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TYMS—lung cancer	4.95e-06	4.65e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.94e-06	4.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—lung cancer	4.93e-06	4.62e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—lung cancer	4.91e-06	4.61e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTM1—lung cancer	4.89e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NCOA3—lung cancer	4.89e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP2E1—lung cancer	4.88e-06	4.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.88e-06	4.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—STK11—lung cancer	4.87e-06	4.57e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA4—lung cancer	4.84e-06	4.55e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TYMS—lung cancer	4.84e-06	4.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NQO1—lung cancer	4.82e-06	4.53e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.8e-06	4.51e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTM1—lung cancer	4.78e-06	4.49e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP2E1—lung cancer	4.76e-06	4.47e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—lung cancer	4.76e-06	4.47e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCG2—lung cancer	4.75e-06	4.46e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ADCY1—lung cancer	4.75e-06	4.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—bone marrow—lung cancer	4.73e-06	0.011	CbGeAlD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.72e-06	4.43e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA2—lung cancer	4.72e-06	4.43e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NQO1—lung cancer	4.71e-06	4.42e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.68e-06	4.39e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—POMC—lung cancer	4.68e-06	4.39e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—lung cancer	4.66e-06	4.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HPGDS—lung cancer	4.66e-06	4.38e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP1A1—lung cancer	4.64e-06	4.35e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.63e-06	4.35e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ERCC2—lung cancer	4.6e-06	4.32e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.57e-06	4.29e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.57e-06	4.29e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CREBBP—lung cancer	4.55e-06	4.28e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA1—lung cancer	4.55e-06	4.27e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—EP300—lung cancer	4.54e-06	4.26e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP1A1—lung cancer	4.53e-06	4.26e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTT1—lung cancer	4.52e-06	4.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTP1—lung cancer	4.51e-06	4.23e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCC3—lung cancer	4.5e-06	4.23e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ERCC2—lung cancer	4.5e-06	4.22e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.49e-06	4.22e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GCLC—lung cancer	4.47e-06	4.2e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2A6—lung cancer	4.47e-06	4.2e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.45e-06	4.18e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP2E1—lung cancer	4.45e-06	4.18e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NQO1—lung cancer	4.4e-06	4.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CAT—lung cancer	4.39e-06	4.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.36e-06	4.09e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKR1C1—lung cancer	4.36e-06	4.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—STK11—lung cancer	4.35e-06	4.08e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CD—lung cancer	4.32e-06	4.05e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.31e-06	4.04e-05	CbGpPWpGaD
Carbamazepine—ABCB1—lung—lung cancer	4.29e-06	0.00999	CbGeAlD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.27e-06	4.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—lung cancer	4.27e-06	4.01e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ALB—lung cancer	4.26e-06	4e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—STK11—lung cancer	4.24e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO1—lung cancer	4.24e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—UGT1A1—lung cancer	4.23e-06	3.97e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.22e-06	3.96e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TYMS—lung cancer	4.19e-06	3.93e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.17e-06	3.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTM1—lung cancer	4.14e-06	3.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.08e-06	3.83e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNG11—lung cancer	4.08e-06	3.83e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTP1—lung cancer	4.02e-06	3.78e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—APOA1—lung cancer	3.98e-06	3.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—STK11—lung cancer	3.96e-06	3.72e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTP1—lung cancer	3.93e-06	3.69e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP1A1—lung cancer	3.93e-06	3.69e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CAT—lung cancer	3.91e-06	3.68e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ERCC2—lung cancer	3.89e-06	3.66e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.89e-06	3.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—APOA1—lung cancer	3.89e-06	3.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALDOA—lung cancer	3.89e-06	3.65e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CAT—lung cancer	3.82e-06	3.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—lung cancer	3.81e-06	3.58e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2E1—lung cancer	3.8e-06	3.57e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOA3—lung cancer	3.77e-06	3.54e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CB—lung cancer	3.76e-06	3.53e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NQO1—lung cancer	3.76e-06	3.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TYMS—lung cancer	3.74e-06	3.51e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—lung cancer	3.73e-06	3.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.72e-06	3.49e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTM1—lung cancer	3.7e-06	3.47e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.68e-06	3.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCG2—lung cancer	3.67e-06	3.45e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ADCY1—lung cancer	3.67e-06	3.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTP1—lung cancer	3.67e-06	3.44e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TYMS—lung cancer	3.65e-06	3.43e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.65e-06	3.42e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—lung cancer	3.63e-06	3.41e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTM1—lung cancer	3.61e-06	3.39e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—lung cancer	3.6e-06	3.38e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HPGDS—lung cancer	3.6e-06	3.38e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.58e-06	3.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CAT—lung cancer	3.57e-06	3.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—lung cancer	3.55e-06	3.33e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.55e-06	3.33e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP1A1—lung cancer	3.5e-06	3.29e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTT1—lung cancer	3.49e-06	3.28e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ERCC2—lung cancer	3.48e-06	3.26e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—lung cancer	3.47e-06	3.26e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—POMC—lung cancer	3.46e-06	3.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2A6—lung cancer	3.45e-06	3.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GCLC—lung cancer	3.45e-06	3.24e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP1A1—lung cancer	3.42e-06	3.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TYMS—lung cancer	3.41e-06	3.2e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ERCC2—lung cancer	3.39e-06	3.19e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—STK11—lung cancer	3.39e-06	3.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—POMC—lung cancer	3.38e-06	3.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTM1—lung cancer	3.37e-06	3.16e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—APOA1—lung cancer	3.37e-06	3.16e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CREBBP—lung cancer	3.37e-06	3.16e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—lung cancer	3.36e-06	3.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CREBBP—lung cancer	3.29e-06	3.09e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO1—lung cancer	3.27e-06	3.07e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—lung cancer	3.25e-06	3.05e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.23e-06	3.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP1A1—lung cancer	3.2e-06	3e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CD—lung cancer	3.19e-06	3e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.18e-06	2.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ERCC2—lung cancer	3.17e-06	2.98e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALB—lung cancer	3.15e-06	2.96e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTP1—lung cancer	3.13e-06	2.94e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CD—lung cancer	3.12e-06	2.93e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—EP300—lung cancer	3.1e-06	2.91e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALB—lung cancer	3.08e-06	2.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—lung cancer	3.08e-06	2.89e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CAT—lung cancer	3.05e-06	2.86e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.03e-06	2.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—APOA1—lung cancer	3.01e-06	2.82e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—lung cancer	2.97e-06	2.79e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—APOA1—lung cancer	2.93e-06	2.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2E1—lung cancer	2.93e-06	2.75e-05	CbGpPWpGaD
Carbamazepine—ABCB1—lymph node—lung cancer	2.93e-06	0.00683	CbGeAlD
Carbamazepine—CYP2C8—Metabolism—POMC—lung cancer	2.93e-06	2.75e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TYMS—lung cancer	2.91e-06	2.74e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NQO1—lung cancer	2.9e-06	2.72e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTM1—lung cancer	2.88e-06	2.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.88e-06	2.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CREBBP—lung cancer	2.85e-06	2.68e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CB—lung cancer	2.78e-06	2.61e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—lung cancer	2.76e-06	2.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—lung cancer	2.74e-06	2.58e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—lung cancer	2.74e-06	2.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—APOA1—lung cancer	2.74e-06	2.57e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.73e-06	2.56e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CB—lung cancer	2.72e-06	2.55e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ERCC2—lung cancer	2.71e-06	2.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CD—lung cancer	2.7e-06	2.54e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—lung cancer	2.7e-06	2.53e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—lung cancer	2.68e-06	2.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALB—lung cancer	2.67e-06	2.51e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.62e-06	2.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—STK11—lung cancer	2.61e-06	2.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—POMC—lung cancer	2.61e-06	2.45e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—POMC—lung cancer	2.55e-06	2.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CREBBP—lung cancer	2.54e-06	2.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—lung cancer	2.5e-06	2.35e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CREBBP—lung cancer	2.48e-06	2.33e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTP1—lung cancer	2.42e-06	2.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CD—lung cancer	2.41e-06	2.27e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—lung cancer	2.41e-06	2.26e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—POMC—lung cancer	2.38e-06	2.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALB—lung cancer	2.38e-06	2.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CB—lung cancer	2.36e-06	2.21e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CD—lung cancer	2.36e-06	2.21e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CAT—lung cancer	2.35e-06	2.21e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—lung cancer	2.35e-06	2.21e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOA1—lung cancer	2.34e-06	2.2e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—lung cancer	2.33e-06	2.19e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALB—lung cancer	2.32e-06	2.18e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CREBBP—lung cancer	2.32e-06	2.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—lung cancer	2.29e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—EP300—lung cancer	2.29e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—lung cancer	2.29e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TYMS—lung cancer	2.25e-06	2.11e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—EP300—lung cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTM1—lung cancer	2.22e-06	2.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CD—lung cancer	2.2e-06	2.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALB—lung cancer	2.17e-06	2.04e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.14e-06	2.01e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.11e-06	1.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.1e-06	1.97e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ERCC2—lung cancer	2.09e-06	1.96e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—lung cancer	2.08e-06	1.96e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CB—lung cancer	2.05e-06	1.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—lung cancer	2.04e-06	1.91e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—POMC—lung cancer	2.04e-06	1.91e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—lung cancer	2.03e-06	1.91e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CREBBP—lung cancer	1.98e-06	1.86e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—EP300—lung cancer	1.94e-06	1.82e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.92e-06	1.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—lung cancer	1.9e-06	1.78e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—lung cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALB—lung cancer	1.86e-06	1.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—lung cancer	1.82e-06	1.71e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOA1—lung cancer	1.81e-06	1.7e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—lung cancer	1.77e-06	1.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—EP300—lung cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—lung cancer	1.7e-06	1.59e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—EP300—lung cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—lung cancer	1.66e-06	1.56e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—lung cancer	1.66e-06	1.56e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.65e-06	1.55e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.64e-06	1.54e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—lung cancer	1.62e-06	1.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—EP300—lung cancer	1.58e-06	1.48e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—POMC—lung cancer	1.57e-06	1.48e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CREBBP—lung cancer	1.53e-06	1.44e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.45e-06	1.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—lung cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALB—lung cancer	1.43e-06	1.35e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—lung cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—lung cancer	1.39e-06	1.3e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—lung cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—EP300—lung cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.28e-06	1.2e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.26e-06	1.19e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—lung cancer	1.25e-06	1.18e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—lung cancer	1.25e-06	1.18e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—lung cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—lung cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—lung cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—lung cancer	1.05e-06	9.84e-06	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—EP300—lung cancer	1.04e-06	9.79e-06	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—lung cancer	1.02e-06	9.6e-06	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—lung cancer	9.99e-07	9.38e-06	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—lung cancer	9.55e-07	8.97e-06	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—lung cancer	8.16e-07	7.66e-06	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—lung cancer	7.71e-07	7.24e-06	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—lung cancer	6.3e-07	5.91e-06	CbGpPWpGaD
